Skip to main content
Premium Trial:

Request an Annual Quote

Dana Farber Taps CLC Bio Platform for NGS Data Analysis

Premium

CLC Bio said this week that the Center for Cancer Computational Biology at the Dana-Farber Cancer Institute has selected CLC's enterprise platform to handle its next-generation sequence analysis needs.

Mick Correll, associate director of the CCCB, said the institute deployed CLC Bio's platform to support an "increasing number of molecular biologists and clinicians who don't have their own bioinformatics resources."

CLC Bio's platform provides "versatile deployment opportunities," he said. "By giving individual groups access to our central installation of the CLC Genomics Server, they can leverage a powerful enterprise platform while only needing to invest in their own desktop clients."

Currently, Dana-Farber os building the data-coordination and -analysis informatics infrastructure for the Lung Genomics Research Consortium, which aims to add genetic, genomic, and epigenetic data and analysis tools to an existing clinical biorepository at the National Heart Lung and Blood Institute (BI 02/11/2011).

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.